Abstract
Background The prevalence of asymptomatic white matter lesions (WML) in patients with sickle cell disease (SCD) has been described to be very frequent in young adults. Cerebrovascular regulation and cardiovascular autonomic regulation, more specifically the sympatho-vagal balance can be altered in SCD.
In this study we assessed the association between WML, cerebrovascular regulation and sympatho-vagal balance in SCD.
Method Adults with no history of stroke from a cohort of SCD patients were prospectively evaluated for, cerebrovascular regulation using Mx for autoregulation, breath holding test for cerebrovascular reactivity and cerebral arterial compliance calculated from arterial blood pressure and cerebral velocities. Sympatho-vagal balance was assessed using heart rate variability parameters. WML was assessed with MRI using Fazekas score grading and the presence of lacunar lesions.
Results Forty-one patients (F/M:25/16) were included. Median age was 37.5 (range 19-65). Twenty-nine (70,7%) patients had SS genotype, 7 patients (17,1%) had SC genotype and 5 (12,2%) patients had Sß° genotype. Among the 41 patients included, 11 patients had WML (26,8%). Patients with WML were significantly older (44.5 vs 30.6 years; p<0.001), had a lower HF (HF 157 ms2 vs HF 467.6 ms2; p<0.005) and impaired cerebral arterial compliance (CaBVR 15.4 vs 37.3 cm3/mmHg; p<0.014). Cerebral blood flow velocities, reactivity to breath holding test and cerebral autoregulation parameters did not significantly differ between the two groups.
Conclusions Lower parasympathetic activity and impaired cerebral arterial compliance were associated with WML in adults with SCD. This could potentially yield to a better understanding of pathophysiological parameters leading to premature cerebrovascular ageing in SCD patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Comité de protection des personnes du CHU de Toulouse
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data referred to in the manuscript were obtained with the consentement of patients
